BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
This Quarter Return
+78.25%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$955M
AUM Growth
+$955M
(+61%)
Cap. Flow
+$123M
Cap. Flow
% of AUM
12.86%
Top 10 Holdings %
Top 10 Hldgs %
91.54%
Holding
15
New
4
Increased
1
Reduced
3
Closed
–
Top Buys
| 1 |
Mersana Therapeutics
MRSN
|
$80.6M |
| 2 |
Spyre Therapeutics
SYRE
|
$25M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$20.8M |
| 4 |
Dynavax Technologies
DVAX
|
$19.2M |
| 5 |
Crinetics Pharmaceuticals
CRNX
|
$18.8M |
Top Sells
| 1 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$24.1M |
| 2 |
Replimune Group
REPL
|
$16.8M |
| 3 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
$555K |
Sector Composition
| 1 | Healthcare | 87.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWTX
1
DELISTED
SpringWorks Therapeutics
SWTX
| $306M | 32.03% | 7,281,307 | – | – |
|
2
Arcutis Biotherapeutics
ARQT
$1.86B
| $120M | 12.6% | 3,979,292 | – | – |
|
|
DRNA
3
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $104M | 10.85% | 4,080,237 | – | – |
|
|
4
Dynavax Technologies
DVAX
$1.19B
| $96.6M | 10.12% | 10,895,773 +2,165,066 | +25% | +$19.2M |
|
|
5
Mersana Therapeutics
MRSN
$36.5M
| $80.6M | 8.44% | +3,445,667 | New | +$80.6M |
|
|
6
Replimune Group
REPL
$422M
| $53.7M | 5.63% | 2,162,598 -676,370 | -24% | -$16.8M |
|
|
CNST
7
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $42.1M | 4.41% | 1,400,000 -803,529 | -36% | -$24.1M |
|
|
8
Spyre Therapeutics
SYRE
$996M
| $25M | 2.62% | +2,700,000 | New | +$25M |
|
|
APTX
9
DELISTED
Aptinyx Inc. Common Stock
APTX
| $23.2M | 2.43% | 5,558,425 | – | – |
|
10
Savara
SVRA
$567M
| $23M | 2.41% | 5,128,593 | – | – |
|
|
SAGE
11
DELISTED
Sage Therapeutics
SAGE
| $20.8M | 2.17% | +499,100 | New | +$20.8M |
|
|
12
Crinetics Pharmaceuticals
CRNX
$2.92B
| $18.8M | 1.97% | +1,071,428 | New | +$18.8M |
|
13
X4 Pharmaceuticals
XFOR
$84.2M
| $15.4M | 1.61% | 1,648,485 | – | – |
|
|
MRNS
14
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $14.5M | 1.52% | 5,724,235 -218,500 | -4% | -$555K |
|
15
Solid Biosciences
SLDB
$427M
| $11.3M | 1.19% | 3,871,164 | – | – |
|